Mandate

Vinge has advised Samhällsbyggnadsbolaget i Norden AB (publ) (”SBB”) in connection with its newly established subsidiary SBB Residential Property AB entering into a capital raise agreement with an investment fund managed by Morgan Stanley Real Estate Investing (“MSREI”).

Pursuant to the agreement, SBB Residential Property AB will issue SEK 2.36 billion of preference shares to MSREI. The preference shares will be issued by an entity to be named SBB Residential Property AB forming a new group within SBB.

Following the transaction, MSREI will hold a minority stake in SBB Residential Property AB. The transaction is subject to customary closing conditions but not competition clearance. Closing will occur as soon as all closing conditions have been fulfilled, which is expected to occur around mid August 2023.

Vinge’s team consisted mainly of Mikael Ståhl, Jesper Schönbeck, Rikard Lindahl, Niclas Winnberg, Helena Göransson, Ulrich Ziche, Maria Dahlin Kolvik, Kristoffer Larsson, Frida Ställborn, Joel Magnusson, Kamyar Najmi, Nour Makie, Ida Redander and Filip Magnusson.

Related

Vinge has advised Oncopeptides in connection with its rights issue

Vinge has advised Oncopeptides AB (publ) in connection with a fully guaranteed rights issue which will provide Oncopeptides with proceeds of approximately SEK 150 million before deduction of transaction costs.
August 28, 2025

Vinge advises Main Capital and Unik in connection with the acquisition of LEB System Aktiebolag

Vinge has advised Unik International ApS (“Unik”), a Danish Housing and Property Management software provider, in connection with the acquisition of LEB System Aktiebolag. The synergistic acquisition is expected to complement and expand Unik’s offering and has a strong strategic fit with Unik and is in line with the company’s internationalization strategy in the Nordic Property Management software market.
August 28, 2025

Vinge has advised Xspray Pharma in connection with its rights issue and debt refinancing

Vinge has advised Xspray Pharma AB (publ) in connection with a rights issue of approximately SEK 130 million before transaction costs, with an over-allotment issue of approximately SEK 20 million, and refinancing of an existing loan.
August 28, 2025